PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: IMARC Group

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

EMR’s New Reports Provide Deep Insight into the Antithrombotic Market of Several Key Countries - A new series of reports from EMR provides an in-depth understanding of the market for Antithrombotic medicines - ExpertMarketResearch.com
EMR’s New Reports Provide Deep Insight into the Antithrombotic Market of Several Key Countries

 

NewswireToday - /newswire/ - Noida, Uttar Pradesh, India, 2011/09/01 - A new series of reports from EMR provides an in-depth understanding of the market for Antithrombotic medicines - ExpertMarketResearch.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

In its new series of reports on Antithrombotic, Expert Market Research, one of the world’s leading providers of lifeScience market intelligence, analyses the market potential of Antithrombotic drugs in several key countries.

EMR’s Antithrombotic market series includes report on the following countries:
UK, France, Italy, Spain, Germany, Vietnam, Egypt, Indonesia, Saudi Arabia, South Africa, Argentina, Thailand, South Korea, Turkey, Mexico, China, India, Russia, Brazil, Canada, Greece, Australia, Japan, US.
Each of these reports provides a comprehensive analysis on the current and future market trends of antithrombotic drugs market. These reports also facilitates a deep insight into the current and future epidemiology of antithrombotic Indications and its market structure besides probing into the performance of various therapeutic classes, companies, molecules and brands. These reports can serve as an excellent guide for clients who are looking for an in-depth understanding of the market for Antithrombotic drugs.

Key Questions Answered in this Report:

• What is the current and future size of the antithrombotic patient population?
• What are the current and future prevalence rates for various antithrombotic indications?
• What has been the historical performance of the Antithrombotic market and how will it behave in the coming years?
• Who are the leading companies in the Antithrombotic market and how will they perform in the coming years?
• What has been the historical performance of various Antithrombotic therapeutic classes and how will they behave in the coming years?
• What are the leading molecules in the Antithrombotic market and how will they behave in the coming years?

Why should you buy this Report?
• To gain an in-depth insight into the prevalence of various Antithrombotic indications.
• To have it as a powerful tool for identifying your target patient population.
• To facilitate business decision-making based on historical, current and forecast market data for Antithrombotic drugs.
• To identify potential classes, drugs, partners and competitors so as to develop strategies for market penetration and drug development
• To develop business strategies by looking at companies those have been the biggest winners and losers in the Antithrombotics market.
• To gain an understanding into future market events and make more informed business decisions.

Research Objectives Achieved in this Report:
Evaluating the Epidemiology of Antithrombotic Indications:
Key Aspects Analyzed:
• Current and future prevalence of various antithrombotic indications
• Current and future size of the patient pool suffering from antithrombotic indications
Comprehensive Situation Analysis of the Antithrombotics Market:
Classes Covered: Platelet Aggregation Inhibitors, Heparins, Fibrinolytics, Vitamin k Antagonists, Direct Thrombin Inhibitors and all other drug classes
Key Aspects Analyzed:
• Historical, current and future market trends.
• Historical, current and future performance of various drugs.
• Historical, current and future performance of various companies.
• Product portfolio of various companies.
• Historical, current and future performance of various therapeutic classes.

Methodology & Information Sources:
To prepare this report, material was mined from both primary and secondary data sources. Primary information sources included data provided by pharmaceutical manufacturers, marketing strategists, scientists, doctors and product managers at leading pharmaceutical companies. Secondary data sources include both proprietary and public databases. These included company websites, annual reports, financial reports, 10K’s, government resources, books, magazines, white papers, journals, analyst reports and access to thousands of proprietary databases.

Table of Contents
1. Research Methodology & Definitions
2. Executive Summary
3. Prevalence of Various Antithrombotic Indications & Patient Population
3.1 Prevalence of Various Antithrombotic Indications
3.2 Antithrombotic Patient Pool
4. The Antithrombotic Drugs Market Landscape
4.1 Current Trends & Forecast
4.1.1 Current Market Trends
4.1.2 Market Forecast
4.2 Share of Various Players & Drugs
4.2.1 Current Trends
4.2.2 Market Forecast
4.3 Performance of Various Therapeutic Classes
4.3.1 Platelet Aggregation Inhibitors
4.3.1.1 Current Market Trends
4.3.1.2 Sales of Various Molecules
4.3.1.3 Sales Forecast
4.3.2 Heparins
4.3.2.1 Current Market Trends
4.3.2.2 Sales of Various Molecules
4.3.2.3 Sales Forecast
4.3.3 Fibrinolytics
4.3.3.1 Current Market Trends
4.3.3.2 Sales of Various Molecules
4.3.3.3 Sales Forecast
4.3.4 Vitamin k Antagonists
4.3.4.1 Current Market Trends
4.3.4.2 Sales of Various Molecules
4.3.4.3 Sales Forecast
4.3.5 Direct Thrombin Inhibitors
4.3.5.1 Current Market Trends
4.3.5.2 Sales of Various Molecules
4.3.5.3 Sales Forecast
4.3.6 Other Classes
4.3.6.1 Current Market Trends
4.3.6.2 Sales of Various Molecules
4.3.6.3 Sales Forecast.

To buy the complete report or to get a free sample Call: +91-880-236-2536 (Asia), +1 206 204-1851 (America & Europe) - E: sales[.]expertmarketresearch.com. To know more please visit: expertmarketresearch.com

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: IMARC Group

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


EMR’s New Reports Provide Deep Insight into the Antithrombotic Market of Several Key Countries

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Keshav Singh - ExpertMarketResearch.com 
+91 12 04155099 press[.]expertmarketresearch.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any IMARC Group securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From IMARC Group / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe
BTG and Mirada Medical Announce CE Mark Certification for Simplicit90Y Dosimetry Software in Europe
FDA Grants Priority Review to Genentech’s Lucentis® (Ranibizumab Injection) Supplemental Biologics License Application
Genentech’s TECENTRIQ® (Atezolizumab) Shows Significant Survival Advantage Compared to Chemotherapy

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  JobsWare.com





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)